Latest On Acro Biomedical Co., Ltd (ACBM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-12-04 06:27 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-27 00:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 07:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-21 07:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 16:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 16:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 21:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-02 23:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 20:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 04:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 07:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 16:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 08:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 19:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-22 19:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-14 03:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 11:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 09:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 20:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:33 EST | Financials | Company financials have been released. | Neutral | |
About Acro Biomedical Co., Ltd (ACBM):
Acro Biomedical Co., Ltd. develops and markets nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine; and metallothionein MT-3 elizer, a protein powder used in health supplements. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was founded in 2014 and is based in Fishers, Indiana.
General
- Name Acro Biomedical Co., Ltd
- Symbol ACBM
- Type Common Stock
- Exchange OTCQB
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Fiscal Year EndDecember
- Web URLhttp://acrobiomedicalco.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 105.82
- Price/Book (Most Recent Quarter) 192.2
- Enterprise Value Revenue 105.84
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin -4%
- Return on Assets -22%
- Revenue 1.46 million
- Revenue Per Share $0.03
- Gross Profit 48384
- Quarterly Earnings Growth -100%
View More
Highlights
- Market Capitalization 155.22 million
- Book Value Per Share $0.02
View More
Share Statistics
- Shares Outstanding 47.76 million
- Shares Float 17.76 million
- % Held by Insiders 6281%
View More
Technicals
- Beta 0.81
- 52 Week High $5.8
- 52 Week Low $1.75
- 50 Day Moving Average 3.02
- 200 Day Moving Average 3.15
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Acro Biomedical Co., Ltd (ACBM) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Acro Biomedical Co., Ltd (ACBM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-09-30 | $N/A | $-0.00 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $-0.00 | ||
| 2020-03-31 | 2020-06-30 | $687964 | $-0.00 | ||
| 2019-12-31 | 2020-03-31 | $193536 | $0.00 | ||
| 2019-09-30 | 2019-09-30 | $N/A | $-0.00 | ||
| 2019-06-30 | 2019-09-30 | $N/A | $-0.00 | ||
| 2019-03-31 | 2019-06-30 | $N/A | $-0.00 | ||
| 2018-12-31 | 2019-03-31 | $1.35 million | $-0.00 | ||
| 2018-09-30 | 2018-09-30 | $2.41 million | $0.00 | ||
| 2018-06-30 | 2018-09-30 | $2.2 million | $0.00 | ||
| 2018-03-31 | 2018-06-30 | $1.96 million | $0.00 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $1.45 million | $0.00 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $510000 | $0.00 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $N/A | $0.00 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $N/A | $-0.00 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $-0.00 | $0.00 | ||
| 2016-09-30 | 2016-12-31 | $-0.00 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $-0.00 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $-0.00 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $-0.00 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $-0.00 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.00 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $-0.00 | $0.00 |
Acro Biomedical Co., Ltd (ACBM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | -63699 | 81116 | -75873 | -65286 |
| Selling General Administrative | N/A | 62771 | 77847 | 87529 | 64460 |
| Gross Profit | N/A | N/A | 159404 | 12096 | N/A |
| Ebit | N/A | -62771 | 81557 | -75433 | -64460 |
| Operating Income | N/A | -62771 | 81557 | -75433 | -64460 |
| Income Tax Expense | N/A | N/A | N/A | N/A | 9871 |
| Total Revenue | N/A | N/A | 687964 | 193536 | N/A |
| Cost of Revenue | N/A | N/A | 528560 | 181440 | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | -440 | -826 |
| Net Income From Continuing Operations | N/A | -63699 | 81116 | -75873 | -75157 |
| Net Income Applicable to Common Shares | -73099 | N/A | 81116 | -75873 | -75157 |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 4000 | N/A | -26226 | -72726 | 104334 |
| Total Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Net Borrowings | 64376 | N/A | 35739 | -35489 | -41633 |
| Total Cash Flow from Financial Activities | N/A | 61576 | 35739 | -35489 | -41633 |
| Change to Operating Activities | 3000 | N/A | -12000 | 1647 | 3000 |
| Change in Cash | N/A | -10255 | 9725 | -561 | 1241 |
| Total Cash from Operating Activities | -64601 | -71831 | -26014 | 34928 | 42874 |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | -588000 | -71440 | 181440 | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 1498 | N/A | 2536 | 440 | 10697 |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 181268 | 139653 | 133887 | 195792 |
| Total Stockholder Equity | N/A | 817025 | 879796 | 798239 | 873672 |
| Other Current Liabilities | 20000 | N/A | N/A | 37464 | 116000 |
| Total Assets | N/A | 998293 | 1.02 million | 932126 | 1.07 million |
| Common Stock | 47760 | N/A | 47760 | 47760 | 47760 |
| Other Current Assets | N/A | N/A | N/A | N/A | 4992 |
| Retained Earnings | -176883 | -103784 | -40085 | -121201 | -45328 |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 4230 | N/A | 4230 | 4230 | N/A |
| Cash | N/A | 381 | 10636 | 911 | 1472 |
| Total Current Liabilities | 239889 | 171268 | 123449 | 111541 | 195792 |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 30721 | N/A | 42583 | 48425 | N/A |
| Total Current Assets | 954156 | 957381 | 972636 | 879471 | 1.07 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 745484 | N/A | 879796 | 798239 | 873672 |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 950000 | 938000 | 350000 | 878560 | 1.06 million |
| Accounts Payable | 5072 | 1072 | 15072 | 23834 | 18024 |
Acro Biomedical Co., Ltd (ACBM) Chart:
Acro Biomedical Co., Ltd (ACBM) News:
Below you will find a list of latest news for Acro Biomedical Co., Ltd (ACBM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Acro Biomedical Co., Ltd (ACBM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Acro Biomedical Co., Ltd (ACBM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-19 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420001279/0001640334-20-001279-index.htm |
| 2017-01-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1622996/000000000017001560/0000000000-17-001560-index.htm |
| 2016-02-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1622996/000164033416000741/0001640334-16-000741-index.htm |
| 2016-03-02 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033416000761/0001640334-16-000761-index.htm |
| 2016-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033416001061/0001640334-16-001061-index.htm |
| 2016-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033416001481/0001640334-16-001481-index.htm |
| 2016-12-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1622996/000164033416002238/0001640334-16-002238-index.htm |
| 2016-12-21 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1622996/000164033416002273/0001640334-16-002273-index.htm |
| 2017-01-17 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000098/0001640334-17-000098-index.htm |
| 2017-01-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000177/0001640334-17-000177-index.htm |
| 2017-02-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000223/0001640334-17-000223-index.htm |
| 2017-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000299/0001640334-17-000299-index.htm |
| 2017-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000937/0001640334-17-000937-index.htm |
| 2017-05-16 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1622996/000164033417000987/0001640334-17-000987-index.htm |
| 2017-05-22 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033417001056/0001640334-17-001056-index.htm |
| 2017-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033417001625/0001640334-17-001625-index.htm |
| 2017-12-29 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1622996/000164033417002745/0001640334-17-002745-index.htm |
| 2018-01-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418000094/0001640334-18-000094-index.htm |
| 2018-01-16 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418000103/0001640334-18-000103-index.htm |
| 2018-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418000321/0001640334-18-000321-index.htm |
| 2018-02-15 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1622996/000164033418000339/0001640334-18-000339-index.htm |
| 2018-03-16 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1622996/000164033418000466/0001640334-18-000466-index.htm |
| 2018-05-16 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001018/0001640334-18-001018-index.htm |
| 2018-06-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001249/0001640334-18-001249-index.htm |
| 2018-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001322/0001640334-18-001322-index.htm |
| 2018-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001489/0001640334-18-001489-index.htm |
| 2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001572/0001640334-18-001572-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033418001967/0001640334-18-001967-index.htm |
| 2018-12-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1622996/000164033418002423/0001640334-18-002423-index.htm |
| 2019-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033419000261/0001640334-19-000261-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033419000877/0001640334-19-000877-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033419001630/0001640334-19-001630-index.htm |
| 2019-12-31 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | https://www.sec.gov/Archives/edgar/data/1622996/000164033419002689/0001640334-19-002689-index.htm |
| 2020-01-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420000007/0001640334-20-000007-index.htm |
| 2020-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033420000108/0001640334-20-000108-index.htm |
| 2020-03-27 | 10-KT | Transition reports [Rule 13a-10 or 15d-10] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420000639/0001640334-20-000639-index.htm |
| 2020-05-18 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1622996/000164033420001257/0001640334-20-001257-index.htm |
| 2020-05-19 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420001279/0001640334-20-001279-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1622996/000164033420002068/0001640334-20-002068-index.htm |
| 2020-08-14 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1622996/000164033420002106/0001640334-20-002106-index.htm |
| 2020-08-19 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420002198/0001640334-20-002198-index.htm |
| 2020-09-08 | 10-12G | Registration of securities [Section 12(g)] | https://www.sec.gov/Archives/edgar/data/1622996/000164033420002297/0001640334-20-002297-index.htm |
| 2016-02-29 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1622996/999999999516003856/9999999995-16-003856-index.htm |
| 2017-01-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1622996/999999999517000232/9999999995-17-000232-index.htm |
| 2018-03-19 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1622996/999999999518000630/9999999995-18-000630-index.htm |